Cas No.: | 1416581-40-2 |
Chemical Name: | 4-(cyclopropyl((3aS,9R,9aR)-7-fluoro-4-(4-(trifluoromethoxy)benzoyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]quinolin-9-yl)amino)-4-oxobutanoic acid |
Synonyms: | MK8318 |
SMILES: | C(O)(=O)CCC(N(C1CC1)[C@@H]1C2=C(N(C(=O)C3=CC=C(OC(F)(F)F)C=C3)[C@@]([H])3CCC[C@@]31[H])C=CC(F)=C2)=O |
Formula: | C27H26F4N2O5 |
M.Wt: | 534.508 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | MK-8318 (MK8318) is a potent, selective, orally available CRTh2 receptor antagonist with Ki of 5 nM, shows nM potency in functional assay (cAMP IC50=8 nM, β-Arrestin IC50=3.5 nM; blocks late airway response (LAR) and airway hyperresponsiveness (AHR) after i.v. infusion at 1 mpk, also displays good efficacy on BAL cells/pulmonary function from ovalbumin sensitized and challenged Brown Norway rats at 3, 10, and 30 mpk oral dosing; MK-8318 exhibits a favorable PK profile suitable for once daily oral dosing for potential treatment of asthma. |